Jump to content

Details

Company database

BMG LABTECH GmbH

Since its establishment in 1990, BMG LABTECH has become a world leader in microplate reading due to continuous development of innovative and unique technologies. BMG LABTECH’s devices are able to perform many types of bioanalytical measurement techniques including fluore- scence intensity, fluorescence polarization, luminescence, time-resolved fluorescence, UV/Vis absorbance, AlphaScreen®, and nephelometry.

With the CLARIOstar® multi-mode microplate reader, the company offers unique and revolutionary LVF monochromatorsTM which provide filter-like performance and increased sensitivity over conventional mono-chromators. The LVF monochromatorsTM, along with filters and a UV/ Vis spectrometer, can be used for a variety of applications in up to eight different detection modes. Thanks to its new Atmospheric Control Unit, the CLARIOstar® can easily provide the physiological environment for any cell type, enhancing cell-based microplate assays.

The PHERAstar® FSX is BMG LABTECH’s most sensitive multi-mode reader for high-throughput screening (HTS). Thanks to the unique optic Module system, Simultaneous Dual Emission, UV/Vis spectrometer, and dedicated AlphaScreen® and TRF Lasers, the PHERAstar® FSX will per- form any application with ease and speed, even in 3456-well microplates.

All microplate readers are manufactured and tested at BMG LABTECH’s headquarters in Ortenberg, Germany, which guarantees their precision, reliability, and robustness. BMG LABTECH continuously works with all of the leading reagent companies to handle the increasingly challenging requirements of popular microplate assays.

Biotech CompaniesAnalytics, DNA/RNA, Proteins/Peptides, Cells/Cell Lines, Devices
Website address: https://www.gesundheitsindustrie-bw.de/en/database/details